OBIO CIK: 1814114

Orchestra BioMed Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
1.80
FY22:
84.7
FY23:
89.1
FY24:
69.2
FY25:
108
(positive)
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
10.9
FY23:
6.10
FY24:
7.00
FY25:
6.95
Total assets
Change from FY21 to FY25
millions USD
FY21:
162
FY22:
95.6
FY23:
95.2
FY24:
76.2
FY25:
115

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
0.17
FY22:
18.6
FY23:
11.2
FY24:
16.2
FY25:
16.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.60
FY22:
24.5
FY23:
16.0
FY24:
27.0
FY25:
34.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.94
FY22:
−6.94
FY23:
68.0
FY24:
33.0
FY25:
53.6
Total liabilities & equity
Change from FY23 to FY24
millions USD
FY21:
–
FY22:
–
FY23:
95.2
FY24:
76.2
FY25:
–

All amounts in millions USD Data source:SEC EDGAR